Any similar listings elsewhere? Would also be intersting to know how much other institutions pay for these journals, and whether the subscription is online, print, or both. Any pointers?
- Daniel Mietchen
from Bookmarklet
:) Elsevier has quite a strong showing on this list...
- Matthew Todd
Daniel: some data available here: http://www.sennoma.net/main... but the linked post makes it quite clear that Elsevier's public price list bears little relationship to what they actually charge.
- Bill Hooker
No, the post is from Allyson, I just shared it...
- Cameron Neylon
This relates to a point Geoff Bilder made in a recent presentation. We have a habit of building systems that work fine when you can trust everyone but which breakdown when you can't. It is a design flaw in many federated systems. And it's hard to build the security back in after the fact.
- Cameron Neylon
I definitely need to make sure I pay more attention to the email-addresses of suggested reviewers. Unbelievable!!
- Björn Brembs
Hmm. This will be HQ because we say it will be HQ. And who are we to doubt. OA is interesting as a kind of clergy push from one end and introduce designedly quality journals while a lot of entrants presumably 'dilute' that (author-pays being the only business model with which they can get new titles off the ground). So can we hit them with sticks to do the right thing (i.e., using candidate standards and best practice docs, not just being open)?
- Chris
from twhirl
Its no more circular than the same arguments for other "top" journals really. But I think you can probably assume that standards and best practice will be pretty high on the agenda. Wellcome have a good record on that.
- Cameron Neylon
Jesus H Christ. They haven't learned anything. "Top-tier journal"? Fuck. We may as well just give up.
- Bill Hooker
They've learned some things, just not others...but remember what the core problem here is. Survey after survey tells us that researchers avoid going OA because there aren't sufficiently prestigious journals. This action goes directly to that issue, not really any other. And because it only seeks to change one thing it may well break through that barrier. Then there will be a clear...
more...
- Cameron Neylon
I don't buy it. After the success (and Impact Factor) of PLoS Biology, I don't see the point in another "prestige OA journal". If PLoS Bio and Medicine weren't enough to kill the "OA != quality" trope, this latest me-too won't help. At least PB/M were supposed to be proving a point; this is just jumping on a bandwagon. (And when is PLoS going to collapse all their journals into ONE? The experiment's done, time for the next step.)
- Bill Hooker
No, this is different for a couple of reasons. One it's coming straight from funders. That will make a hell of a difference in a way a third party play like PLoS couldn't. This is the people with the money. The other is that now that PB/M have broken down the barriers on the quality issue there is an opportunity to push further. Yes we know that that difference is meaningless but it matters for most researchers.
- Cameron Neylon
Funny thing is of course I was at that meeting saying exactly the same things you are...never had so many Nobel Laureates disagreeing with me at once....
- Cameron Neylon
The other point is that the other message here isn't for researchers, its for publishers. Wellcome &c are saying that they're not happy with the current levels of service so they are going to do their damndest t introduce serious competition. This is a clear statement that the status quo of 6 month embargoes and or NC restrictions or high fees isn't good enough in their view....
- Cameron Neylon
Let's hope they spend the money on a decent, machine readable, semantic, journal platform, that really changes publishing and doesn't destroy scientific data, and let's up their ideal of a top-tier journal is not another Cell, Nature, or Science.
- Egon Willighagen
And I am clueless how they will get *active* *top* scientists do a decent review in 1-2 weeks...
- Egon Willighagen
By having topper activer scientists as editors to ride herd on them? No I don't know either...
- Cameron Neylon
Late to this - been at work. I'm all for OA as y'all know. Have mixed views on this one though as matters stand and from the discussion above. I guess the bit that irk's me (and I'm with Bill on this one although I also see where Cameron is coming from too) is the "top-tier" thing. We know about Gold/Green/Gray OA. This sounds to me like bringing the lurgy of IF back into the equation and creating a new brand of OA Publishing - let's dub it "Polished Gold" OA. Do we really need that - SRSLY ??
- Graham Steel
Coming from a different side, I think that such move might do much more for spreading the OA in countries in C&E Europe than most of the things done so far (because PB/M hadn't been sufficiently prestigious here, while anything branded by Wellcome, MPG and HHMI is perceived much better). At the fundamental level it's all wrong, but in short term it may translate into way quicker adoption, as it (as Cameron notes) significantly changes dynamics in the system.
- Pawel Szczesny
I like "polished Gold OA" as the name for this. I understand Cameron's argument and Pawel's European corollary but I am still firmly on the curmudgeonly side of this one. How many Polished Gold journals will it take? How many more concessions and accomodations to publishers and to the Way It's Always Been Done? I don't care for this bit either -- "The long-term business model will be...
more...
- Bill Hooker
A couple of comments on this. First, regarding "impact" I'll keep re-stating my position that until we have a working sorting mechanism for post-peer review publishing we need the tiered journal system. Just imagine doing research with pubmed but no journal tittles. The flood of papers is really impossible to manage without filters and the tiered journals is our currently poor but...
more...
- Pedro Beltrao
Bill, while I again agree fundamentally with you, I think there's a small catch in here in the issue of expensiveness of prestige. PLoS had virtually no prestige when they started and I tend to think (but I have no data) that $3K per article wasn't enough to cover all the aggressive marketing they were doing to become prestigious. Institutions involved in here don't need to spend...
more...
- Pawel Szczesny
So where (physically) will it be based, if anywhere? I suppose Cambridge is too much to hope for as I look for jobs :\
- Chris
from twhirl
More seriously, is there a limit to demand for OA? Presumably PLoS looked at that before starting. I just wonder if there'll be a squeeze. I also think that this enterprise's backers need to be stumping up for some serious storage for supplementary data deposition / sharing.
- Chris
Apparently they will (anonymously) publish review comments...
- Chris
from twhirl
And while not on the subject, would this be a +circle or a +spark..?
- Chris
from twhirl
Yes, Neil, and thanks. I was asking a bit in the other direction because the Neanderthal genome paper was already on our list. If anyone knows of a supplement exceeding these 175 pages (which includes 51 figures and 58 tables), though, please share it here.
- Daniel Mietchen
Thanks for pointing me to the Neanderthal paper. Used the info in a presentation today.
- Martin Fenner
Just noticed that the above comment by @neilfws is gone. I was sad to see him leave, but I understood the reasoning behind that. I do not understand why he deleted the account. For the record, the paper he mentioned is at http://www.sciencemag.org/content... .
- Daniel Mietchen
Bjorn, Daniel I assume he simply forgot the lesson of Eva Amsen (she also left FF deleting account) assuming that it's like the Facebook - you delete account and everything stays anyway.
- Pawel Szczesny
Cool, Pete - and thanks for leading the crowd once more.
- Daniel Mietchen
Well, not quite (some others beat us to it, including Springer, Elsevier, Mendeley) but we have been wanting to do this for ages. Plus ours is on the full text and fully open.
- Peter Binfield
I meant the "full text and fully open" part.
- Daniel Mietchen
Speaking of PubMed, one of its major limitations is that it does not provide full-text search. PLoS and Mendeley do. So I think it would be useful to have a little app (e.g. a browser plugin) that takes a PubMed search, passes it on to the PLoS/ Mendeley search engines and displays the results in the context of the original PubMed search. Anyone interested in that (e.g. as a warm-up for http://ff.im/FIwlT )?
- Daniel Mietchen
Couple of updates for any of you entering the competition. Nephoscale are offering 10 free cloud servers for entrants using PLoS APIs see: http://blogs.plos.org/plos... And today we upgraded search to also include "search within figure caption" so now you can do cool things with our figures too.
- Peter Binfield
Lawrence Souder presented on this at the SLA this week (analyzing Redfield's blog posts and related communication) - links to his screencast and slides through here http://ff.im/FUaus
- Jean-Claude Bradley
I'm aggregating a list of resources (not rants!) about evaluating research and research impact at: http://beyond-impact.ietherpad.com/11... Additions v welcome!
Expect public ORCID service in Spring 2012, developer access a little bit earlier. Will aim to work with PubMed Author ID (and other author identifier systems).
- Martin Fenner
I like the end of it where they say "rapidly evolving area" :) ... I obviously have no idea of the challenges involved but from the outside it looks nothing like "rapidly evolving".
- Pedro Beltrao
I remain of the view that there are also very large opportunities for publishers getting into this arena to mismanage the process catastrophically...but will be very interesting to see...
- Cameron Neylon
Just watched/listened to this. @Cameron, I would be interested if you could expand a bit on your comment. Some observations that are new from Pete's previous talks/slides. 1) In the advent of PLoS ONE receiving an IF in July 2010, in Q3 2010, 1500 publications and in Q2 2011, about 3400. That is a massive increase. 2) This (in turn) leads to a projected figure of > 22,000 publications for 2011
- Graham Steel
3) Projection (albeit based on some basic modelling) that by 2016, about 50% of STM Manuscripts will be published in OA Mega Journals. It will be interesting to see how this plays out over that projected time-frame. Good talk, Pete.
- Graham Steel
I wonder how much staff is needed to manage 22K submissions at a reasonable speed (obviously more than it is hired right now ;) ). PLoS is turning into Mega Publisher.
- Pawel Szczesny
Congratulations to the PLoS team but... would it not be prudent to shift the conversation from the large volume to the post-processing metrics ? I think at this point it is not worth keep pointing out that PLoS ONE is growing so much. I keep hearing from colleagues this idea of PLoS ONE as a "dumping ground" and people confusing the PLoS brand in general with PLoS ONE. Since PLoS is not...
more...
- Pedro Beltrao
Well, as you can imagine - it is on the list and we are working on these things as fast as possible! Unfortunately development takes time. In the meantime, part of the beauty of OA is that we dont have to build it all ourselves. We have our Search API and (very) soon an API for our ALM program. The combination of these 2 could be used by anyone to build the tools you are suggesting.
- Peter Binfield
I would've had two questions after the talk: 1. Now that PLoS as a whole has been sustainable since 2010, when will the subsidizing of the community journals by PLoS One authors stop? I don't have cash burning holes in my university pockets and I'd rather only pay for my next PLoS One paper and not for the paper of a PLoS Biology author. If I'm paying for PLoS Biology, I'd like to publish there as well, please.
- Björn Brembs
2. If the Mega-Journals become the new hype and (because?) people start to realize that container means nothing, why would people chose one journal over another (both for publishing and for reading)? Surely, the 'neuroscience' tag in PLoS One doesn't mean anything different than a 'Open Mega-Journal of Neuroscience'?
- Björn Brembs
@Graham, will add that to the list of blog posts that I need to write..Bjoern two reasons presumably. Price and services offered, which would be a step forward in my view beyond current obsession with journal brand.
- Cameron Neylon
lol @Cameron: that's what I'm currently writing a blog post on. From the description, services are identical (minus IF) as are prices. One more reason for PLoS to have 'realistic' pricing for PLoS One, IMHO!
- Björn Brembs
I'd rephrase Bjoern's q1 as: now that PLoS has proven that OA journals can play the Glamor Mag game, PLoS Bio/Med etc have served their pupose -- so when will they be rolled into PLoS ONE?
- Bill Hooker
Waiting to see some familiar names on the contest registrant list.
- Mr. Gunn
from Android
In terms of the OA Mega Journal, what about BMC? Current portfolio of 216 Journals. Would it make any sense or not to move some or all of these over to a "BMC ONE" type Mega Journal? @Egon see this rather cool Mendeley/PLoS mashup http://www.youtube.com/watch...
- Graham Steel
I was going to post my slides with proper screen notes. Any recommendations to record the presentation using a webcam?
- copystar
If you're telling how Calibre can make *valid* ePubs, I'd love to hear more. [Valid = passing validation tests enough so Lulu will accept them for iBooks sales.]
- Walt Crawford
Walt, I will only mention the quality of the epub generation in passing as this is geared as an introductory session to epub. I'm just going to introduce the idea of epub generation 1) by hand (using tools like Sigil) 2) by Wordpress plugins (like Anthologize and PressBooks) 3) by word processing software (Scrivener) and 4) by web services such as Feedbooks. Mileage will vary - but I won't go into detail by how much...
- copystar
Mita: Sounds about right. I was admittedly disappointed that Calibre's HTML-to-epub conversion yielded results that looked great (from Word's filtered HTML with no page headers/footers) on Calibre and were useless for upload. Some day...
- Walt Crawford
After a few firm emails, it seems there is a chance of a corrected pdf. Come on PLoS ONE, you can do this.... Please!
- Jan Wessnitzer
Jan, are you ranting as an author or an editor? If you're a P.ONE editor you can post to the discussion forums, which might help to get things done. (Or might not -- I've never tried taking a problem there. But it can't hurt, I guess.)
- Bill Hooker
Ranting as an author! I am making progress though as Plos 1 have agreed to submit a "republication request".
- Jan Wessnitzer
PHEW - good to know that, Jan. Thanks !!
- Graham Steel
Why don't PLoS provide a proof though? All this could have been prevented by involving the authors a bit more in the very last stage of the publication process. Anywho, something PLoS could and should improve upon.
- Jan Wessnitzer
Thanks again for the input, Jan. I am sure that the 'powers that be' at PLoS are a listening. If I may, I shall induce a <musical interlude> http://www.youtube.com/watch... in the interim.
- Graham Steel
Columnist for the SFChronicle decided to walk the entire line (around the block, thousands of people) waiting for Steve Jobs' keynote at the Apple conference. His finding: of several thousand people in line, 42 were women. His comment: "There's a reason they call them stereotypes."
I can't link to it; most columnists and local feature stories are reserved for print and digital subscribers--yes, including iPad--until two days later, when they appear on SFGate.
- Walt Crawford
I think it's fair to assume that the columnist was not celebrating this number, just pointing out that the Apple developer community is a boy's club just as much as other techie groups are.
- Walt Crawford
[And yes, I did deliberately say "boy's club."]
- Walt Crawford
I could swear that he also mentioned that Scopus has an API - and that if we provided enough demand they would subscribe - from what you say in your post it sounds like you think it is worth the cost?
- Jean-Claude Bradley
If Sciverse is a route in then Remko Caprio (at the meeting tomorrow) may be able to help
- Cameron Neylon
Anyone know someone at Elsevier? Seems like giving a personal subscription to Heather would be very good value for money for them (advertising, developer suggestions, etc). E.g. Michael Habib (Scopus product manager) is @habib on Twitter, I'd write him myself but we've only met once, surely someone on here has at least drunk beer with him?
- Bill Hooker
Thanks for that link for requesting access to SciVerse Developer! I hadn't seen that. Sweet. I have attempted to ask a few people at Scopus for access, but so far to no avail.
- Heather Piwowar
Thanks JC. I did know about the Scopus API, but my understanding is that it is only available for publishers/instituions to use to show metrics about their papers, not for researchers to access bulk citations. Part of the problem is that it is very hard to know who to ask these technical questions... I haven't been very successful in getting useful feedback from my institutional...
more...
- Heather Piwowar
I've shared a beer with Michael, but I don't think I'd necessarily have any pull. I can ask...
- Mr. Gunn
@MrG, I just meant that anything's better than a cold-call, which is what email from me would amount to.
- Bill Hooker
We use both the WoS and Scopus APIs at MPOW. I'm pretty sure you have to be an institutional subscriber for both of them. I would definitely start by contacting Michael Habib - he can probably point you in the right direction if he's not the one. I know someone at Science Direct, but that won't help you. Scopus first level tech support is surprisingly horrible.
- Christina Pikas
"Go and ask your fellow postdoctoral researchers in the biology, chemistry, medicine,… fields what it is their main goal. I’m always getting the same answer: I’m developing a cure for cancer (replace cancer by your “favourite” disease”). In fact, this is a big lie."
- Mr. Gunn
from Bookmarklet
Oh this is a nice sharp exposition of this idea. Definitely like...and need to write something similar and scathing soon as well...
- Cameron Neylon
"That is the approach taken by the Howard Hughes Medical Institute, the largest private supporter of medical research in the U.S. It has selected some 330 researchers with a demonstrated track record of success, as well as 50 up-and-coming young scientists, and annually distributes about $500 million among them with a minimum of red tape. In 2009 three economists compared this system with the standard National Institutes of Health grant. The NIH grants last three years, end abruptly if they are not renewed and have very strict requirements—for instance, preventing scientists from shifting money from a project that is not working out to a more promising approach. Howard Hughes grants last for five years, are usually renewed, provide a grace period even if not continued and encourage reallocation of resources on the fly. The economists found that Howard Hughes grants led to higher-impact research, even when the researchers were compared with an equally elite sample of NIH applicants."
- Kubke
from Bookmarklet